• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一组204株耐氨苄西林肠杆菌科细菌中鉴定出的质粒介导的β-内酰胺酶。

Plasmid-determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae.

作者信息

Roy C, Foz A, Segura C, Tirado M, Fuster C, Reig R

出版信息

J Antimicrob Chemother. 1983 Nov;12(5):507-10. doi: 10.1093/jac/12.5.507.

DOI:10.1093/jac/12.5.507
PMID:6608515
Abstract

Information is presented on the plasmid-determined beta-lactamases identified in 204 strains of ampicillin-resistant Enterobacteriaceae. The type most frequently identified was TEM-1 (in 85.3% of the strains), followed by SHV-1 (14.70%). Two types of plasmid-determined beta-lactamase were identified in 20 strains; in 18 of them one of the two was TEM-1 and in 13, SHV-1 (the TEM-1 + SHV-1 combination was observed in 12 strains). In the 41 Klebsiella strains the most frequently identified enzyme was SHV-1 (in 28 of the strains) and the proportion of strains with two plasmid-determined beta-lactamases was higher than in the other species studied.

摘要

本文介绍了在204株耐氨苄西林肠杆菌科细菌中鉴定出的由质粒介导的β-内酰胺酶。最常见的类型是TEM-1(占菌株的85.3%),其次是SHV-1(14.70%)。在20株细菌中鉴定出两种由质粒介导的β-内酰胺酶;其中18株中两种酶之一是TEM-1,13株中是SHV-1(12株中观察到TEM-1 + SHV-1组合)。在41株克雷伯菌中,最常鉴定出的酶是SHV-1(28株),并且具有两种由质粒介导的β-内酰胺酶的菌株比例高于其他研究的菌种。

相似文献

1
Plasmid-determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae.在一组204株耐氨苄西林肠杆菌科细菌中鉴定出的质粒介导的β-内酰胺酶。
J Antimicrob Chemother. 1983 Nov;12(5):507-10. doi: 10.1093/jac/12.5.507.
2
Prevalence and distribution of R plasmid mediated beta-lactamases in Enterobacteriaceae.
Microbiologica. 1982 Jul;5(3):179-84.
3
[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].[肠杆菌科细菌对β-内酰胺酶抗生素的耐药机制]
Acta Med Croatica. 2004;58(4):307-12.
4
Evaluation of plasmid-encoded beta-lactamase resistance in Escherichia coli blood culture isolates.对大肠杆菌血培养分离株中质粒编码的β-内酰胺酶耐药性的评估。
Eur J Clin Microbiol Infect Dis. 1988 Oct;7(5):651-5. doi: 10.1007/BF01964244.
5
High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.葡萄牙肠杆菌科临床分离株中广谱β-内酰胺酶的高度多样性。
J Antimicrob Chemother. 2007 Dec;60(6):1370-4. doi: 10.1093/jac/dkm381. Epub 2007 Oct 3.
6
Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy.瑞典新生儿病房肠杆菌中质粒介导的β-内酰胺酶的流行病学及其与抗菌治疗的关系
Antimicrob Agents Chemother. 1992 May;36(5):989-92. doi: 10.1128/AAC.36.5.989.
7
Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae.肠杆菌科细菌中β-内酰胺酶产生与对β-内酰胺类抗生素耐药性的相关性
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1982 Sep;252(4):480-9.
8
[Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].[头孢克肟在肠杆菌科细菌产生的β-内酰胺酶类型存在时的抗菌作用]
Presse Med. 1989 Oct 11;18(32):1560-6.
9
Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.使用一组产β-内酰胺酶的肠杆菌科细菌对阿莫西林-克拉维酸和氨苄西林-舒巴坦进行体外药敏试验结果的相关性
APMIS. 1998 Sep;106(9):917-20.
10
Extended-spectrum beta-lactamases in clinical isolates of enterobacteria in Mexico.
Microb Drug Resist. 1999 Fall;5(3):189-93. doi: 10.1089/mdr.1999.5.189.

引用本文的文献

1
Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.应对产β-内酰胺酶 ESKAPE 病原体的新兴策略。
Int J Mol Sci. 2020 Nov 12;21(22):8527. doi: 10.3390/ijms21228527.
2
Community-Acquired Urinary Tract Infection by in the Era of Antibiotic Resistance.社区获得性耐药淋病奈瑟菌尿路感染。
Biomed Res Int. 2018 Sep 26;2018:7656752. doi: 10.1155/2018/7656752. eCollection 2018.
3
Past and Present Perspectives on β-Lactamases.β-内酰胺酶的过去与现在观点。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01076-18. Print 2018 Oct.
4
The use of platensimycin and platencin to fight antibiotic resistance.使用扁枝衣霉素和扁枝衣菌素对抗抗生素耐药性。
Infect Drug Resist. 2013 Sep 18;6:99-114. doi: 10.2147/IDR.S25076.
5
Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.从临床到病床:β-内酰胺酶在抗生素耐药革兰氏阴性感染中的作用。
Crit Care. 2010;14(3):224. doi: 10.1186/cc8892. Epub 2010 Jun 29.
6
Updated functional classification of beta-lactamases.β-内酰胺酶的功能分类更新。
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76. doi: 10.1128/AAC.01009-09. Epub 2009 Dec 7.
7
The role of natural environments in the evolution of resistance traits in pathogenic bacteria.自然环境在病原菌抗性性状进化中的作用。
Proc Biol Sci. 2009 Jul 22;276(1667):2521-30. doi: 10.1098/rspb.2009.0320. Epub 2009 Apr 8.
8
Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea.导致旅行者腹泻的沙门氏菌临床分离株对几种抗菌药物的耐药机制
Antimicrob Agents Chemother. 2004 Oct;48(10):3934-9. doi: 10.1128/AAC.48.10.3934-3939.2004.
9
Frequency of plasmid-mediated beta-lactamases in Enterobacteriaceae isolated in Spain.
Eur J Clin Microbiol Infect Dis. 1993 Jan;12(1):67-9. doi: 10.1007/BF01997065.
10
Penicillins. A current review of their clinical pharmacology and therapeutic use.青霉素。对其临床药理学和治疗用途的当前综述。
Drugs. 1993 Jun;45(6):866-894. doi: 10.2165/00003495-199345060-00002.